U.S. market projected to reach USD 13.18 Billion and Europe USD 13.96 Billion by 2035 as cell and gene therapy outsourcing ...
New York, New York--(Newsfile Corp. - March 25, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, today ...
) has been revised to $46.88 / share. This is an increase of 10.66% from the prior estimate of $42.36 dated April 27, 2026. The price target is an average of many targets provided by analysts. The ...
PENNINGTON, N.J. and SAN DIEGO, May 13, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (Nasdaq:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral cancer ...
As Advanced Therapeutic Medicinal Products (ATMPs) surge in popularity and the market sees an increase in therapy development and available products, contemporary manufacturing processes must align ...
The European Union has a challenging task ahead as it strives to harmonize regulations on advanced therapy medicinal products. The European Medicines Agency is approving a growing number of advanced ...
Cubic Global Defense will work alongside Lockheed Martin to support the US Army’s Training Aids, Devices, Simulators and Simulations (TADSS) Maintenance Program (ATMP), Cubic announced on 20 March.
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results